Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey Gosox, what it tells me is they are doing what’s needed to be done to progress this forward to UpList. Imo, we have a legit, honest team of people putting together a legitimate business..
it’s just a matter of short time before we not only get the UpList, but we also really start seeing REVS coming in.. We have a crazy low entry point here, with only upside potential to this stock imo.
$LVVV
LVVV jumping to .0201 is pretty far off. Looks like LVVV will be in the .11 range in due time. The PPS has come close to this already, and will most likely even CRUSH this in short time.
$LVVV Doing it RIGHT
Exactly, when that door opens, and it will imo.. Will be a HUGE boon for the sector as a whole. Profits will skyrocket..plus better financing options etc..
$LVVV
Exactly here, maybe not as fast as some would like...but things are getting done...credibility is DEFINITELY growing for me..a great team in general imo, doing it the right way..
And most importantly we’re now just entering into a major growth phase of this company.. I’m feeling an LVVV bonanza is on our way!!
Holy cow, there sure looks like there are LOTS OF GOODIES coming our way looking at that report!
$LVVV is gonna be a BEAST!
I noticed a payout to Jeff H recently? Could it be we may be something on the Canadian front soon??
$LVVV
Picking up Steam
Congress can open financial institutions to legal cannabis industry with SAFE Banking Act
Federal statutes create risk for banks that want to operate in the cannabis space. Banks face the threat of civil actions, asset forfeiture, reputational risk, and even criminal penalties if they do business with customers in the cannabis industry. Further, because most banks will not touch cannabis money, the growers, processors, and retailers in the industry must often operate on a cash-only basis. The Internal Revenue Service has even had to build “cash rooms” to accommodate taxes paid by legal cannabis companies. Lawful businesses therefore have to decide between investing heavily in security that other businesses do not need or making themselves easy targets for would-be armed robbers.
That could be changing soon. Last month, the House Financial Services Committee voted 45 to 15 in favor of a bill that would protect banks from punishment by federal regulators for providing financial services to cannabis businesses. Rep. Ed Perlmutter (D-Colo.) introduced the bipartisan SAFE Banking Act, which would prevent federal regulators from punishing financial institutions who provide services to cannabis businesses that are operating legally under state law. During the markup, Rep. Steve Stivers (R-Ohio), offered an amendment to extend the bill’s protections to insurers, which the committee agreed to include. The bill now moves to the House Judiciary Committee for consideration. It has 165 co-sponsors including 17 Republicans.
This month, Sens. Jeff Merkley (D-Ore.), Cory Gardner (R-Colo.), and twenty co-sponsors filed a companion version of the SAFE Banking Act that would shield banks that hold accounts for state-approved marijuana businesses. The bill would require banks to comply with current Financial Crimes Enforcement Network (FinCEN) guidance, while at the same time allowing FinCEN guidance to be streamlined over time as states and the federal government adapt to legalized medicinal and recreational cannabis policies. Both bills are still subject to debate and could undergo substantive changes; industry’s lobbying efforts are far from over. Neither the House bill nor the Senate bill is scheduled for a vote on the floor, but the bills’ sponsors are optimistic.
“Forcing legal businesses to operate in all-cash is dangerous for our communities,” said Merkley. “It’s absurd that cannabis business owners have to shuttle around gym bags full of cash to take care of their taxes or pay their employees. Operating in cash is an invitation to robbery, money laundering, and organized crime. This is a public safety issue, and I hope that this will be the Congress when we build a bipartisan consensus to put this common-sense fix into law.”
“Conflicting federal and state marijuana laws make it difficult for legitimate businesses to use the basic financial services they need access to and this bipartisan legislation gives them that access they need,” said Gardner. “We must also take into account the risk to public safety as these businesses are being forced to carry around bags of money to pay for their employees and rent. Legal businesses should not be treated like this, and I’m glad that Republicans and Democrats are working together to address this issue.”
The SAFE Banking Act has broad support, including from the American Bankers Association (ABA), Credit Union National Association (CUNA), Independent Community Bankers of America (ICBA), Law Enforcement Action Partnership (LEAP), the Electronic Transactions Association (ETA), the National Cannabis Industry Association (NCIA), Mid-Size Bank Coalition of America (MBCA), The Real Estate Roundtable, and various U.S. trade associations such as the American Land Title Association (ALTA), American Property Casualty Insurance Association (APCIA) and the Reinsurance Association of America (RAA).
In a recent House hearing, Treasury Secretary Steven Mncuhin also encouraged Congress to look at the issue on a bipartisan basis, noting “there is a conflict between federal and state law that we and the regulators have no way of dealing with.” He added, “[t]here is not a Treasury solution to this. There is not a regulator solution to this.” The FinCen guidance issued five years ago clarifies how financial institutions can service cannabis businesses in a manner consistent with Bank Secrecy Act obligations, but that guidance goes only so far. Federal Reserve Chairman Jerome Powell therefore recently stated during a Senate hearing, “Financial institutions and their regulators and supervisors are in a very difficult position here with marijuana being illegal under federal law and legal under a growing number of state laws.”
On April 15, 2019, top financial regulators from 25 states echoed that sentiment. Specifically, the regulators urged Congress “to consider legislation that creates a safe harbor for financial institutions to serve a state-compliant business or entrusts sovereign states with the full oversight and jurisdiction of marijuana-related activity.” According to the regulators, led by Pennsylvania Secretary of Banking and Securities Robin L. Wiessmann, “[e]stablishing a safe harbor for banks to serve these entities would help reduce the risk associated with large cash-and-carry operations and bring the safeguards, activities, and sales associated with this business into the regulatory reporting compliance framework.” Regulators from both red and blue states, including Alaska, Colorado, Connecticut, Georgia, Hawaii, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Montana, New Jersey, New Mexico, New York, North Dakota, Oklahoma, Oregon, Utah, Washington, West Virginia, and Wisconsin, co-signed the letter. “While there are unresolved and differing opinions concerning marijuana policy, at the state and federal level, banking services availability has bipartisan support and is agnostic about the other issues pertaining to marijuana,” they stated. The regulators concluded, “We must work together to look for solutions rather than ignoring the new policy landscape.”
The question therefore seems to be not whether banks will have the legal assurance they need to conduct business with the cannabis industry, but when. Increased support from industry will speed up the timeline, so engaging with Congress is critical. Once the legislative and regulatory framework exists, though, many will scramble to understand the precise regulations that banks and their cannabis customers will have to follow to comply with the law. When in doubt, businesses and their bankers should consult legal counsel, particularly in the rapidly evolving compliance landscape for medical and recreational marijuana.
Ohhh yeah, i think so.. I mean really, this beast needs to bust loose at some point.. Maybe Revs are really the key here.. and Bill stepping out of his comfort zone and actually PRing some NUMBERS, PROJECTIONS of what we can look forward too.. This i think will set a buying frenzy here.
Until then, I will HUG my shares stuffed in my pillow. LOL!!
$LVVV
All I know is I am for sure glad they are in REV MODE, knowing they are slammed busy, it seems prudent to be a little "forgiving" at least on a date error to a letter given to its shareholders.. LoL
For me, it had more meaning that he at least had the dignity to let us know where we are at in the Up List process! He could have just as well sent NOTHING, and leave everyone guessing to where we were at.. So yeah, fix the date Bill.. But i understand it was a "mistake" so i have no issue with it.. KEEP LINING THOSE DEALS UP BILL!! This Stock is BOUND To skyrocket at some point!!
$LVVV FTW
I did, that was nice! At least he let us know something of what was going on with the UpList rather than not saying anything. lol
$LVVV..
Livewire CEO to Shareholders on OTCQB Up-listing
I know it has been a while since we announced that we were planning to up-list to OTCQB in November of last year and we realize it has taken longer than anticipated. We had researched the requirements for up-listing to OTCQB and based on our findings, we moved ahead with our application, expecting a relatively smooth and timely process. In December of 2018 we posted audited financials for 2016 and 2017 and filed our OTCQB Certification application as required by OTC Markets.
In January of 2019 we filed our quarterly report for Q3 2018 and additional QB supporting documents for a final review by OTC Markets, as required before final approval of our up-listing application. After the review by OTC we were informed that certain disclosures formatting needed to be amended and reposted.
Due to timing deadlines for the filing of our Annual Report 2018, we had to decide on whether to continue making the requested changes to the quarterly report or prepare and file our audited annual report, since we fully expected that OTC would now request the Annual Report to back up our application for up-listing. We chose to focus on the annual report and to post the unaudited financials while the audit is getting finalized. We’re confident that our reapplication combined with the audited Annual Report for 2018 will meet the requirements for OTCQB up-listing, and I’m hopeful that this will take place in the next 60 days.
We will follow up soon with more detail on our business projects that are currently in the making and moving along nicely.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. specializes in identifying and monetizing current and future trends in the health and wellness industry, with a focus on the cannabis sector. The Company acquires, manages and licenses specialized real estate locations for fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California. Through its subsidiary GHC Ventures it has been awarded several permits for the Company’s nursery locations in California as well as a Statewide distribution license. The Company is also entering into research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes dosing verification of zero-pesticide products for quality brands via the Company’s “7X Pure” Cannabis Dosing and Verification System, and development and licensing of legal, high-quality cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the Unites States Controlled Substance Act.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results and performance, events or circumstances, and actual events may differ materially. Factors that may cause actual results to differ materially from any projections may include, without limitation, delays in the development of its products, the impact of significant new or changing government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s inability to obtain additional financing for the implementation of the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.
This is what I was told
“Attorney letter in respect to the filing - getting done.
And formatting to OTC Pink requirements - getting done
We just keep pushing through all this stuff.”
It’s gonna come down, so, while some may not like it, and prefer to complain, it is, what it is...
$LVVV
It is probably something simple they needed to do, i.e. sign some paperwork , im sure it will be down soon.
$LVVV
Absolutely nothing. Have you even looked into what they are doing? LOL It takes money to make money, and i am tickled pink to see where all the money is going. GROWTH OF THE COMPANY.. Millions to grow this business, to make MULTI MILLIONS Back?? Of course.. If the Canadian companies can dilute MILLIONS UPON MILLIONS and still hit a BIL CAP, So can LVVV in the BEST LOCATION IN THE WORLD.. They have as great a chance as any out there.
$LVVV
Agree 100%. LVVV is even a good Pink Sheet Company. Without the hype LVVV has a lot to invest in.
A company that just landed 3 DISTRIBUTION AGREEMENTS, a Company that is in process of building out a 25 SQFT CLONE GROWING FACILITY, A company that now has 4 PODS GROWING AND SELLING CLONES IN COACHELLA AS WE SPEAK. A company that is in process of an UP LIST TO QB, A company that has as much potential as ANY other MJ company out there and MORE. LEGIT MJ company in one of the best locations to be in the entire world.
Thats what i think.
$LVVV FTW
LVVV giving NEW news now proving they are a LEGIT MJ Business, the PPS from consolidating more on volume that is pretty much readying itself to go up again here. Hopefully those that want IN are able to take advantage of this great opportunity and can get a huge ROI on their investment in the near future.
$LVVV FTW
Market agreeing as LVVV's Share price continues to consolidate day after day.
LVVV's share price is WAY too low for what they have actually delivered
Its a great time to add and get in on a starter position is what that is. I have yet to see any other publicly owned MJ Company doing the same as LVVV is, that even compares. Especially trading at these levels.. ITS WAY UNDERVALUED for what they have going on now.
$LVVV
Hardly! LOL! .. it sure helps to pay attention and actually read and know whats going on with the company. They are making some of their BIGGEST MOVES yet, starting a stream of REVS coming in, which is what we all been waiting for. Its just a matter of time now before this really takes off imo.
$LVVV
Yesterday is old news? WOW! LOL!
$LVVV
LiveWire Ergogenics Announces Distribution and Private Label Agreement with Basso Botanicals - First Manufacturer to Implement LiveWire’s 7X Pure™ Dosing and Verification System
Anaheim, CA – April 16, 2019 - LiveWire Ergogenics, Inc. (OTC: LVVV) announced today the Company has entered into a Distribution and Private Label Agreement with Basso Botanicals, a manufacturer of organically grown, full-plant, full-spectrum, active hemp oil extracts in a variety of products to help people and animals experience its various health benefits and promote a healthy lifestyle. Basso Botanicals will also be the first manufacturer to implement LiveWire’s 7X Pure™ Dosing and Verification system to ensure consumers Basso products are of the highest quality.
Basso Botanicals was founded in 2017 by Dale Halle and a group of individuals with a passion for the cannabis industry. This passion evolved further with the gathering of in-depth knowledge about the benefits of CBD and how it has been helping specific ailments or conditions for human and veterinarian applications that conventional medicine could not always adequately address. The Company’s mission is to be an industry leader in providing the highest quality CBD and cannabis products to aid in a variety of medical conditions and support healthy living.
Bill Hodson, CEO of LiveWire Ergogenics, Inc states, “Dale’s passion for quality and transparency, translate into some of the best products I’ve seen in the industry. We share a vision for the future, not only in product development and distribution channels, but also the importance of an extremely high set of standards, and the 7X Pure ™ Dosage and Verification system fits perfectly . Basso Botanicals is well-respected in the industry and its quest to develop only the highest quality pharmaceutical grade products for the consumer perfectly mirrors LiveWire’s approach to a changing cannabis industry whose customers’ demand clean, high-quality and certified product. This relationship supports our continued efforts to become the leading, vertically integrated cannabis company.”
Basso Botanicals’ forward-thinking management team is working diligently to provide organically grown, full-plant, full-spectrum CBD in a variety of products. These products currently include tinctures/oils, topicals, gel caps, gummies, and dog treats that are of the highest quality elements and tested free of THC. Basso Botanicals provides the highest quality full-spectrum, whole plant extractions from Hemp plants grown in America. This process ensures that all essential vitamins, minerals, fatty acids, proteins, and anti-oxidants are available in all products
Basso Botanicals’ pharmaceutical grade products are THC-free, non-GMO, and free from any harmful preservatives or added ingredients with third-party lab certification identifying the contents of all our products. For more information visit https://bassobotanicals.com
Basso Botanicals is the first manufacturer that will implement LiveWire’s 7X Pure™ Dosing and Verification system to verify and certify the dosing and pureness of all products manufactured by Basso and distributed by LiveWire. LiveWire’s plan is to establish its 7X Pure™ Verification System as the gold standard in the industry. For more information please visit 7xPure.com
In cooperation with Basso Botanicals’ team LiveWire will also begin the development and production of Private Label LiveWire 7X Pure™ tested high-end CBD and cannabis products and market and distribute these products worldwide.
For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For nonmaterial updates, follow LiveWire Ergogenics on Twitter @livewireLVVV. Download the Stockwatchindex Research Report at www.swiresearch.com/report-index.
*** LVVV NEWS!! CA MJ UP AND COMING PLAYER CONTINUES MAKING ITS MOVES! MASSIVE POTENTIAL! ***
LiveWire Ergogenics Announces Distribution and Private Label Agreement with Basso Botanicals - First Manufacturer to Implement LiveWire’s 7X Pure™ Dosing and Verification System
Anaheim, CA – April 16, 2019 - LiveWire Ergogenics, Inc. (OTC: LVVV) announced today the Company has entered into a Distribution and Private Label Agreement with Basso Botanicals, a manufacturer of organically grown, full-plant, full-spectrum, active hemp oil extracts in a variety of products to help people and animals experience its various health benefits and promote a healthy lifestyle. Basso Botanicals will also be the first manufacturer to implement LiveWire’s 7X Pure™ Dosing and Verification system to ensure consumers Basso products are of the highest quality.
Basso Botanicals was founded in 2017 by Dale Halle and a group of individuals with a passion for the cannabis industry. This passion evolved further with the gathering of in-depth knowledge about the benefits of CBD and how it has been helping specific ailments or conditions for human and veterinarian applications that conventional medicine could not always adequately address. The Company’s mission is to be an industry leader in providing the highest quality CBD and cannabis products to aid in a variety of medical conditions and support healthy living.
Bill Hodson, CEO of LiveWire Ergogenics, Inc states, “Dale’s passion for quality and transparency, translate into some of the best products I’ve seen in the industry. We share a vision for the future, not only in product development and distribution channels, but also the importance of an extremely high set of standards, and the 7X Pure ™ Dosage and Verification system fits perfectly . Basso Botanicals is well-respected in the industry and its quest to develop only the highest quality pharmaceutical grade products for the consumer perfectly mirrors LiveWire’s approach to a changing cannabis industry whose customers’ demand clean, high-quality and certified product. This relationship supports our continued efforts to become the leading, vertically integrated cannabis company.”
Basso Botanicals’ forward-thinking management team is working diligently to provide organically grown, full-plant, full-spectrum CBD in a variety of products. These products currently include tinctures/oils, topicals, gel caps, gummies, and dog treats that are of the highest quality elements and tested free of THC. Basso Botanicals provides the highest quality full-spectrum, whole plant extractions from Hemp plants grown in America. This process ensures that all essential vitamins, minerals, fatty acids, proteins, and anti-oxidants are available in all products
Basso Botanicals’ pharmaceutical grade products are THC-free, non-GMO, and free from any harmful preservatives or added ingredients with third-party lab certification identifying the contents of all our products. For more information visit https://bassobotanicals.com
Basso Botanicals is the first manufacturer that will implement LiveWire’s 7X Pure™ Dosing and Verification system to verify and certify the dosing and pureness of all products manufactured by Basso and distributed by LiveWire. LiveWire’s plan is to establish its 7X Pure™ Verification System as the gold standard in the industry. For more information please visit 7xPure.com
In cooperation with Basso Botanicals’ team LiveWire will also begin the development and production of Private Label LiveWire 7X Pure™ tested high-end CBD and cannabis products and market and distribute these products worldwide.
For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For nonmaterial updates, follow LiveWire Ergogenics on Twitter @livewireLVVV. Download the Stockwatchindex Research Report at www.swiresearch.com/report-index.
*** LVVV NEWS!! CA MJ UP AND COMING PLAYER CONTINUES MAKING ITS MOVES! MASSIVE POTENTIAL! ***
LiveWire Ergogenics Announces Distribution and Private Label Agreement with Basso Botanicals - First Manufacturer to Implement LiveWire’s 7X Pure™ Dosing and Verification System
Anaheim, CA – April 16, 2019 - LiveWire Ergogenics, Inc. (OTC: LVVV) announced today the Company has entered into a Distribution and Private Label Agreement with Basso Botanicals, a manufacturer of organically grown, full-plant, full-spectrum, active hemp oil extracts in a variety of products to help people and animals experience its various health benefits and promote a healthy lifestyle. Basso Botanicals will also be the first manufacturer to implement LiveWire’s 7X Pure™ Dosing and Verification system to ensure consumers Basso products are of the highest quality.
Basso Botanicals was founded in 2017 by Dale Halle and a group of individuals with a passion for the cannabis industry. This passion evolved further with the gathering of in-depth knowledge about the benefits of CBD and how it has been helping specific ailments or conditions for human and veterinarian applications that conventional medicine could not always adequately address. The Company’s mission is to be an industry leader in providing the highest quality CBD and cannabis products to aid in a variety of medical conditions and support healthy living.
Bill Hodson, CEO of LiveWire Ergogenics, Inc states, “Dale’s passion for quality and transparency, translate into some of the best products I’ve seen in the industry. We share a vision for the future, not only in product development and distribution channels, but also the importance of an extremely high set of standards, and the 7X Pure ™ Dosage and Verification system fits perfectly . Basso Botanicals is well-respected in the industry and its quest to develop only the highest quality pharmaceutical grade products for the consumer perfectly mirrors LiveWire’s approach to a changing cannabis industry whose customers’ demand clean, high-quality and certified product. This relationship supports our continued efforts to become the leading, vertically integrated cannabis company.”
Basso Botanicals’ forward-thinking management team is working diligently to provide organically grown, full-plant, full-spectrum CBD in a variety of products. These products currently include tinctures/oils, topicals, gel caps, gummies, and dog treats that are of the highest quality elements and tested free of THC. Basso Botanicals provides the highest quality full-spectrum, whole plant extractions from Hemp plants grown in America. This process ensures that all essential vitamins, minerals, fatty acids, proteins, and anti-oxidants are available in all products
Basso Botanicals’ pharmaceutical grade products are THC-free, non-GMO, and free from any harmful preservatives or added ingredients with third-party lab certification identifying the contents of all our products. For more information visit https://bassobotanicals.com
Basso Botanicals is the first manufacturer that will implement LiveWire’s 7X Pure™ Dosing and Verification system to verify and certify the dosing and pureness of all products manufactured by Basso and distributed by LiveWire. LiveWire’s plan is to establish its 7X Pure™ Verification System as the gold standard in the industry. For more information please visit 7xPure.com
In cooperation with Basso Botanicals’ team LiveWire will also begin the development and production of Private Label LiveWire 7X Pure™ tested high-end CBD and cannabis products and market and distribute these products worldwide.
For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For nonmaterial updates, follow LiveWire Ergogenics on Twitter @livewireLVVV. Download the Stockwatchindex Research Report at www.swiresearch.com/report-index.
Not sure Gosox, it’s mind boggling for me lol... legit MJ company in CA, with clear potential to CRUSH it? Just with what they have going now it seems we should be trading at .10 or higher... long as they continue doing what they are doing now, it’s gotta catch up at some point imo.
The company has been making some of its biggest moves EVER and one complains?? LOL!! Thats silly, it takes money to make money, relative to size of what they are accomplishing. It doesn't take much to speculate on what potential can come out of a 25k sqft clone space. let alone 3 new distribution agreements in place, and not to mention even Coachella even! ALREADY NOW SELLING CLONES! Yeah, once again, Millions to get this up and running in exchange for MULTI MILLIONS in return? I will take that any day.. If companies like Aurora can dilute MILLIONS UPON MILLIONS and still end up at a BIL CAP.. LVVV has every chance and more to do the same imo.
$LVVV
Examples of other companies similar to LVVV.. That is what im referencing..everything they are doing has been expected and really means squat now anyways at this stage of the game. This year will be telling on their REVS coming in, and establishing of ROBLES 25k sqft facility.
WAY UNDERVALUED right now with all they have going on.
$LVVV
Based on what? Give us some examples please. Of course, that would be impossible im sure. LOL They are doing EXACTLY what we expect and now that they are operating with REVS coming in.. A mil a month is PEANUTS compared to what they will be doing soon.
$LVVV
All of LVVV's Financial Reports have been expected ones for a start up MJ Company. No wonder PPS is going to EXPLODE inevitably at some point. These guys are doing it RIGHT! Not many LEGIT MJ companies to invest in at this price! CHEAP and WAY UNDERVALUED for what they have going on now.
$LVVV
LiveWire Ergogenics Announces Distribution and Private Label Agreement with Basso Botanicals - First Manufacturer to Implement LiveWire’s 7X Pure™ Dosing and Verification System
BAM! $LVVV
THey are obviously slammed busy over there.
*** LVVV NEWS!! ***
LiveWire Ergogenics Announces Distribution and Private Label Agreement with Basso Botanicals - First Manufacturer to Implement LiveWire’s 7X Pure™ Dosing and Verification System
Anaheim, CA – April 16, 2019 - LiveWire Ergogenics, Inc. (OTC: LVVV) announced today the Company has entered into a Distribution and Private Label Agreement with Basso Botanicals, a manufacturer of organically grown, full-plant, full-spectrum, active hemp oil extracts in a variety of products to help people and animals experience its various health benefits and promote a healthy lifestyle. Basso Botanicals will also be the first manufacturer to implement LiveWire’s 7X Pure™ Dosing and Verification system to ensure consumers Basso products are of the highest quality.
Basso Botanicals was founded in 2017 by Dale Halle and a group of individuals with a passion for the cannabis industry. This passion evolved further with the gathering of in-depth knowledge about the benefits of CBD and how it has been helping specific ailments or conditions for human and veterinarian applications that conventional medicine could not always adequately address. The Company’s mission is to be an industry leader in providing the highest quality CBD and cannabis products to aid in a variety of medical conditions and support healthy living.
Bill Hodson, CEO of LiveWire Ergogenics, Inc states, “Dale’s passion for quality and transparency, translate into some of the best products I’ve seen in the industry. We share a vision for the future, not only in product development and distribution channels, but also the importance of an extremely high set of standards, and the 7X Pure ™ Dosage and Verification system fits perfectly . Basso Botanicals is well-respected in the industry and its quest to develop only the highest quality pharmaceutical grade products for the consumer perfectly mirrors LiveWire’s approach to a changing cannabis industry whose customers’ demand clean, high-quality and certified product. This relationship supports our continued efforts to become the leading, vertically integrated cannabis company.”
Basso Botanicals’ forward-thinking management team is working diligently to provide organically grown, full-plant, full-spectrum CBD in a variety of products. These products currently include tinctures/oils, topicals, gel caps, gummies, and dog treats that are of the highest quality elements and tested free of THC. Basso Botanicals provides the highest quality full-spectrum, whole plant extractions from Hemp plants grown in America. This process ensures that all essential vitamins, minerals, fatty acids, proteins, and anti-oxidants are available in all products
Basso Botanicals’ pharmaceutical grade products are THC-free, non-GMO, and free from any harmful preservatives or added ingredients with third-party lab certification identifying the contents of all our products. For more information visit https://bassobotanicals.com
Basso Botanicals is the first manufacturer that will implement LiveWire’s 7X Pure™ Dosing and Verification system to verify and certify the dosing and pureness of all products manufactured by Basso and distributed by LiveWire. LiveWire’s plan is to establish its 7X Pure™ Verification System as the gold standard in the industry. For more information please visit 7xPure.com
In cooperation with Basso Botanicals’ team LiveWire will also begin the development and production of Private Label LiveWire 7X Pure™ tested high-end CBD and cannabis products and market and distribute these products worldwide.
For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For nonmaterial updates, follow LiveWire Ergogenics on Twitter @livewireLVVV. Download the Stockwatchindex Research Report at www.swiresearch.com/report-index.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. specializes in identifying and monetizing current and future trends in the health and wellness industry, with a focus on the cannabis sector. The Company acquires, manages and licenses specialized real estate locations for fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California. Through its subsidiary GHC Ventures it has been awarded several permits for the Company’s nursery locations in California as well as a Statewide distribution license. The Company is also entering into research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes dosing verification of zero-pesticide products for quality brands via the Company’s “7X Pure” Cannabis Dosing and Verification System, and development and licensing of legal, high-quality cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the Unites States Controlled Substance Act.
Ohhh yeah, maybe they will burn double that this year! But then maybe adding on 3 or 4 more locations, more state licensing, massive clone sale orders, slew more distribution agreements...
How much do you think 25k sqft of space dedicated to clone sales can earn?? yeah, 11 mil gonna be chump change here soon! LOL...
$LVVV
Quite frankly, this is great imo. Quarterly reports mean nothing at this stage of the company, I would continue to expect losses going forward. LVVV is about future growth in an incredible market, which is piping hot and still in its infancy stage. Over the next 2-3 years when the stock is in the dollars we can care about the quarterly report.
Regardless, there's going to be continued growth from what im seeing, and that's all anyone should really care about right now. GROWTH AND REVS TO COME.
See you at .30+
$LVVV
CEO still working the company great like that huh? The financials for LVVV are otw to being GREAT!.
$LVVV
When will LVVV create and deliver revenue? Well, if one would take the time to actually read the PRs being delivered, one would know they are already generating REVS now. Also they would know there is NO TOXIC debt with this company.
$LVVV
LVVV has been stating a lot of things. LVVV will continue deliver as ususal. LVVV is a good company to hold but not a good flip. One can never understand how someone flipping this stock can pay their bills.. Such a travesty!
LOL..highly doubtful, especially knowing they are doing all this by the book, to be fully compliant and transparent, etc.. but we will find out for sure shortly...
With Bill H being the CEO of GHC Ventures and LVVV , expecting lots of transparency when the financial reports come out next week
Must be nice for the CEO of GHC Ventures to have a LEGIT MJ business with smart LVVV shareholders holding long and strong